Previous Close | 13.73 |
Open | 13.44 |
Bid | 12.70 x 1300 |
Ask | 12.64 x 2900 |
Day's Range | 13.21 - 13.56 |
52 Week Range | 12.85 - 30.41 |
Volume | |
Avg. Volume | 5,007,932 |
Market Cap | 2.257B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.34 |
Earnings Date | Jul 23, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 19.55 |
Amidst varied financial results, Teladoc Health Inc (TDOC) outlines strategic initiatives for international expansion and enhanced platform innovations.
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
First Quarter Results Highlighted by Revenue Growth and Adjusted EBITDA Increase